Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia

Journal of Urology

Volumn 175, Issue 3, 2006, Pages 1023-1027

  Sung, Jeffrey C ^a,b   Curtis, Lesley H ^a   Schulman, Kevin A ^a,b,c   Albala, David M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Doxazosin; Finasteride; Male; Prostatic hyperplasia; Tamsulosin; Urologic surgical procedures

Indexed keywords

FINASTERIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; GEOGRAPHIC INFORMATION SYSTEM; HEALTH CARE PLANNING; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY;

ADRENERGIC ALPHA-ANTAGONISTS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; UNITED STATES; UROLOGIC SURGICAL PROCEDURES;

EID: 32044468734     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00409-X     Document Type: Article

References (17)

1. M.J. Barry, F.J. Fowler Jr., L. Bin, J.E. Oesterling A nationwide survey of practicing urologists current management of benign prostatic hyperplasia and clinically localized prostate cancer J Urol 158 1997 488
2. J.D. McConnell, R. Bruskewitz, P. Walsh, G. Andriole, M. Lieber, H.L. Holtgrewe Finasteride Long-Term Efficacy and Safety Study Group The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia N Engl J Med 338 1998 557
3. J.D. McConnell, C.G. Roehrborn, O.M. Bautista, G.L. Andriole Jr., C.M. Dixon, J.W. Kusek The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2003 2387
4. Hetzel, L. and Smith, A.: The 65 Years and Over Population: 2000. Washington, D.C.: US Census Bureau; 2001. Available at http://www.census.gov/ prod/2001pubs/c2kbr01-10.pdf. Accessed December 20, 2004
5. R.S. Stafford, C.D. Furberg, S.N. Finkelstein, I.M. Cockburn, T. Alehegn, J. Ma Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002 JAMA 291 2004 54
6. P. Diehr, K. Cain, F. Connell, E. Volinn What is too much variation? The null hypothesis in small-area analysis Health Serv Res 24 1990 741
7. K. McPherson, P.M. Strong, A. Epstein, L. Jones Regional variations in the use of common surgical procedures within and between England and Wales, Canada and the United States of America Soc Sci Med [A] 15 1981 273
8. S.J. Pocock, D.G. Cook, S.A. Beresford Regression of area mortality rates on explanatory variables what weighting is appropriate? J R Stat Soc Ser C Appl Stat 30: 1981 286
9. G.L. Lu-Yao, A.L. Potosky, P.C. Albertsen, J.H. Wasson, M.J. Barry, J.E. Wennberg Follow-up prostate cancer treatments after radical prostatectomy a population-based study J Natl Cancer Inst 88 1996 166
10. C.J. Mettlin, G.P. Murphy, M.P. Cunningham, H.R. Menck The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment Cancer 80 1997 1261
11. K. McPherson, J.E. Wennberg, O.B. Hovind, P. Clifford Small-area variations in the use of common surgical procedures an international comparison of New England, England, and Norway N Engl J Med 307 1982 1310
12. A. Britton, M. McKee, N. Black, K. McPherson, C. Sanderson, C. Bain Threats to applicability of randomised trials exclusions and selective participation J Health Serv Res Policy 4: 1999 112
13. B. Akduman, E.D. Crawford Terazosin, doxazosin, and prazosin current clinical experience Urology 58 suppl. 2001 49
14. C. Chapple, K.E. Andersson Tamsulosin an overview World J Urol 19 2002 397
15. M.J. Manyak, S.J. Ackerman, M.L. Blute, A.L. Rein, K. Buesterien, E.M. Sullivan Cost effectiveness of treatment for benign prostatic hyperplasia an economic model for comparison of medical, minimally invasive, and surgical therapy J Endourol 16 2002 51
16. R.F. Donnell Changes in medicare reimbursement impact on therapy for benign prostatic hyperplasia Curr Urol Rep 3 2002 280
17. M. Blute, S.J. Ackerman, A.L. Rein, K. Beusterien, E.M. Sullivan, C.P. Tanio Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia part II-results Urology 56: 2000 981